Skip to main navigation

Linkedin
Twitter
Facebook

Company
Pipeline
- Overview
- LUM-201 for PGHD
Partnering
- Partnering & Collaboration
Patients
- Advocacy and Patients
- Growth Deficiencies
Careers
- Culture
- Benefits
- Jobs
Investors & Media
Contact
- Contact Us
- Our Offices

Company ►
Pipeline ►
- Overview
- LUM-201 for PGHD
Partnering ►
- Partnering & Collaboration
Patients ►
- Advocacy and Patients
- Growth Deficiencies
Careers ►
- Culture
- Benefits
- Jobs
Investors & Media ►
Contact ►
- Contact Us
- Our Offices

IR Banner

Home > Investors > Quarterly Results Quarterly Results

Quarterly Results

Show all

2020

Third Quarter

Lumos Pharma Announces the Initiation of Phase 2b OraGrowtH210 Trial and Reports Third Quarter 2020 Financial Results
Lumos Pharma, Inc. Third Quarter 2020 Earnings Conference Call

Second Quarter

Lumos Pharma Reports Second Quarter 2020 Results and Provides Update on Clinical and Corporate Activities
Lumos Pharma, Inc. Second Quarter 2020 Earnings Conference Call
Form 10-Q

First Quarter

Lumos Pharma Reports First Quarter 2020 Results and Provides Update on Clinical and Corporate Activities
Lumos Pharma, Inc. First Quarter 2020 Earnings Conference Call
Form 10-Q

Email Alerts Subscription

Download Library

Search Investors

Facebook
LinkedIn
Twitter

Stay Connected

Receive updates on the latest news from Lumos Pharma.

Email

Linkedin
Twitter
Facebook

Company
Pipeline
- Overview
- LUM-201 for PGHD
Partnering
- Partnering & Collaboration
Patients
- Advocacy and Patients
- Growth Deficiencies
Careers
- Culture
- Benefits
- Jobs
Investors & Media
Contact
- Contact Us
- Our Offices

Privacy Policy
Compassionate Use Policy
Terms of Use
© 2020 Lumos Pharma
Site By CreativePickle